| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |